We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

AI Program Could Aid Decision-Making in Medical Imaging

By HospiMedica International staff writers
Posted on 24 Sep 2018
Image: The Explainable Artificial Intelligence (XAI) program can help with decision-making in various medical fields (Photo courtesy of Raytheon BBN Technologies).
Image: The Explainable Artificial Intelligence (XAI) program can help with decision-making in various medical fields (Photo courtesy of Raytheon BBN Technologies).
Researchers are developing a first of its kind neural network that explains itself and could help with decision-making in the medical field, among others. Raytheon BBN Technologies (Cambridge, MA, USA) is developing the neural network under the Defense Research Project Agency's (DARPA) Explainable Artificial Intelligence program (XAI). The aim of the XAI program is to create a suite of machine learning techniques, which produce more explainable models while maintaining a high level of performance. It also aims to help human users understand, appropriately trust and effectively manage the emerging generation of artificially intelligent partners.

The Explainable Question Answering System (EQUAS) by Raytheon BBN will allow Artificial Intelligence (AI) programs to 'show their work,' increasing the human user's confidence in the machine's suggestions. EQUAS will show users which data mattered most in the AI decision-making process. Using a graphical interface, users can explore the system's recommendations and see why it chose one answer over another. Although the technology is still in its early phases of development, it has the potential to be used for a wide-range of applications. As the system is enhanced, EQUAS will be able to monitor itself and share factors that limit its ability to make reliable recommendations. This self-monitoring capability will help developers refine AI systems, allowing them to inject additional data or change how data is processed.

"A fully developed system like EQUAS could help with decision-making not only in DoD operations, but in a range of other applications like campus security, industrial operations and the medical field," said Bill Ferguson, lead scientist and EQUAS principal investigator at Raytheon BBN. "Say a doctor has an x-ray image of a lung and her AI system says that its cancer. She asks why and the system highlights what it thinks are suspicious shadows, which she had previously disregarded as artifacts of the X-ray process. Now the doctor can make the call – to diagnose, investigate further, or, if she still thinks the system is in error, to let it go."

Related Links:
Raytheon BBN Technologies

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
VTE Prevention System
Flowtron ACS900
New
Short Phlebotomy Cart
MSWA-3469-WHT

Channels

Surgical Techniques

view channel
Image: For the first time, a fluorescent-guided nerve imaging agent has shown promise for use in humans (Photo courtesy of VUMC)

Fluorescent Imaging Agent ‘Lights Up’ Nerves for Better Visualization During Surgery

Surgical nerve injury is a significant concern in head and neck surgeries, where nerves are at risk of being inadvertently damaged during procedures. Such injuries can lead to complications that may impact... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more